| The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders A Merlo, R Turrini, R Dolcetti, D Martorelli, E Muraro, P Comoli, A Rosato haematologica 95 (10), 1769, 2010 | 136 | 2010 |
| Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation J Duraiswamy, R Turrini, A Minasyan, D Barras, I Crespo, AJ Grimm, ... Cancer cell 39 (12), 1623-1642. e20, 2021 | 128 | 2021 |
| Role of CD4+ Cytotoxic T Lymphocytes in the Control of Viral Diseases and Cancer D Martorelli, E Muraro, A Merlo, R Turrini, A Rosato, R Dolcetti International reviews of immunology 29 (4), 371-402, 2010 | 75 | 2010 |
| Adoptive cell therapy against EBV-related malignancies: a survey of clinical results A Merlo, R Turrini, R Dolcetti, P Zanovello, A Amadori, A Rosato Expert opinion on biological therapy 8 (9), 1265-1294, 2008 | 66 | 2008 |
| Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors A Merlo, R Turrini, S Bobisse, R Zamarchi, R Alaggio, R Dolcetti, ... The Journal of Immunology 184 (10), 5895-5902, 2010 | 62 | 2010 |
| TIE-2 expressing monocytes in human cancers R Turrini, A Pabois, I Xenarios, G Coukos, JF Delaloye, MA Doucey Oncoimmunology 6 (4), e1303585, 2017 | 60 | 2017 |
| PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function M Morotti, AJ Grimm, HC Hope, M Arnaud, M Desbuisson, N Rayroux, ... Nature 629 (8011), 426-434, 2024 | 57 | 2024 |
| Exploiting the Interplay between Innate and Adaptive Immunity to Improve Immunotherapeutic Strategies for Epstein‐Barr‐Virus‐Driven Disorders D Martorelli, E Muraro, A Merlo, R Turrini, DA Fae, A Rosato, R Dolcetti Journal of Immunology Research 2012 (1), 931952, 2012 | 57 | 2012 |
| TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer S Bron, L Henry, E Faes-Van'T Hull, R Turrini, D Vanhecke, N Guex, ... Oncoimmunology 5 (2), e1073882, 2016 | 56 | 2016 |
| Immunotherapy for EBV-associated malignancies A Merlo, R Turrini, R Dolcetti, P Zanovello, A Rosato International journal of hematology 93, 281-293, 2011 | 39 | 2011 |
| Bone marrow-derived cells are implicated as a source of lymphatic endothelial progenitors in human breast cancer. E Faes van’t Hull, S Bron, L Henry, A Ifticene-Treboux, R Turrini, ... Oncoimmunology 3 (e29080), 2014 | 24 | 2014 |
| Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST) R Alaggio, R Turrini, D Boldrin, A Merlo, C Gambini, A Ferrari, P Dall'Igna, ... PloS one 8 (11), e80456, 2013 | 23 | 2013 |
| ISB 1342: A first-in-class CD38 T cell engager for the treatment of relapsed refractory multiple myeloma. MA Doucey, B Pouleau, C Estoppey, C Stutz, A Croset, A Laurendon, ... Journal of Clinical Oncology 39 (15_suppl), 8044-8044, 2021 | 19 | 2021 |
| IGKV3 Proteins as Candidate “Off-the-Shelf” Vaccines for Kappa-Light Chain–Restricted B-Cell Non-Hodgkin Lymphomas D Martorelli, M Guidoboni, V De Re, E Muraro, R Turrini, A Merlo, E Pasini, ... Clinical Cancer Research 18 (15), 4080-4091, 2012 | 19 | 2012 |
| A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors R Turrini, A Merlo, D Martorelli, DA Fae, R Sommaggio, IM Montagner, ... Oncoimmunology 6 (4), e1304338, 2017 | 17 | 2017 |
| Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer R Turrini, A Merlo, R Dolcetti, P Zanovello, A Rosato Cancer Immunology, Immunotherapy 60, 1639-1645, 2011 | 9 | 2011 |
| Impact of γ-chain cytokines on EBV-specific T cell cultures A Merlo, R Turrini, C Trento, P Zanovello, R Dolcetti, A Rosato Journal of translational medicine 8, 1-8, 2010 | 6 | 2010 |
| A combined computational and experimental approach to successfully predict the behavior of metastatic tumor-associated macrophages in human breast cancer A Bekkar, A Pabois, I Crespo, R Turrini, I Xenarios, MA Doucey bioRxiv, 2025.02. 06.636799, 2025 | | 2025 |
| Anti-BARF1 monoclonal antibody A Rosato, R Turrini, R Dolcetti, D Martorelli, DA Fae US Patent 10,933,133, 2021 | | 2021 |
| IGKV3 proteins as candidate “off-the-shelf” vaccines for kappa-light chain-restricted B cell non-Hodgkin’s lymphomas (156.15) R Dolcetti, D Martorelli, M Guidoboni, V De Re, E Muraro, R Turrini, ... The Journal of Immunology 186 (1_Supplement), 156.15-156.15, 2011 | | 2011 |
